Augmentation of 5-lipoxygenase activity and expression during dengue serotype-2 infection

Virology Journal

Volumn 10, Issue , 2013, Pages

  Loke, Wai Mun ^a   Chow, Angelia Yee ^b   Lam Mok Sing, Karen ^a   Lee, Chung Yung J ^a,c   Halliwell, Barry ^c   Lim, Erle Ch ^a   Quek, Amy Ml ^a   Ooi, Eng Eong ^b   Seet, Raymond Cs ^a  

^a Dept Medicine Endocrinol Diabet   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

5 lipoxygenase activities; Dengue; Inflammation; Leukotriene B ssub 4 esub

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ANTIGEN; ARACHIDONATE 5 LIPOXYGENASE; C REACTIVE PROTEIN; LEUKOTRIENE B4;

ARTICLE; CONVALESCENCE; CYTOKINE PRODUCTION; DENGUE; DENGUE VIRUS 2; FEVER; IN VITRO STUDY; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; VIRUS REPLICATION;

ADULT; ARACHIDONATE 5-LIPOXYGENASE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CELLS, CULTURED; DENGUE; FEMALE; HUMANS; LEUKOTRIENE B4; MALE; NEUTROPHILS; SEROTYPING;

EID: 84886543884     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-10-322     Document Type: Article

References (39)

1. The global distribution and burden of dengue. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. Nature 2013 doi:10.1038/nature12060
2. Dengue prevention and 35 years of vector control in Singapore. Ooi EE, Goh KT, Gubler DJ, Emerg Infect Dis 2006 12 887 893 16707042
3. Oxidative damage in dengue fever. Seet RCS, Lee CY, Lim ECH, Quek AML, Yeo LL, Huang SH, Halliwell B, Free Rad Biol Med 2009 47 375 380 10.1016/j.freeradbiomed.2009.04.035 19427377
4. Inflammatory mediators in dengue virus infection in children: Interleukin-8 and its relationship to neutrophil degranulation. Juffrie M, Van der Meer GM, Hack CE, Haasnoot K, Sutaryo A, Veerman AJP, Thijs LG, Infect Immun 2000 68 702 707 10.1128/IAI.68.2.702-707.2000 10639436
5. Dengue virus and endothelial cell: a related phenomenon to thrombocytopenia and granulocytopenia in dengue hemorrhagic fever. Butthep P, Bunyaratvej A, Bhamarapravati N, Southeast Asian J Trop Med Public Health 1993 24 246 249 7886587
6. Defensins: antimicrobial peptides of innate immunity. Ganz T, Nat Rev Immunol 2003 3 710 720 10.1038/nri1180 12949495
7. Cathelicidins: a family of endogenous antimicrobial peptides. Lehrer RI, Ganz T, Curr Opin Hematol 2002 9 18 22 10.1097/00062752-200201000-00004 11753073
8. Leukotriene B§ssub§4§esub§: metabolism and signal transduction. Yokomizo T, Izumi T, Shimizu T, Arch Biochem Biophys 2001 385 231 241 10.1006/abbi.2000.2168 11368003
9. Role of Leukotriene B§ssub§4§esub§ receptors in the development of atherosclerosis: potential mechanisms. Subbarao K, Jala VR, Mathis S, Suttles J, Zacharias W, Ahamed J, Ali H, Tseng MT, Haribabu B, Arterioscler Thromb Vasc Biol 2004 24 369 375 14656734
10. Leukotriene B§ssub§4§esub§ triggers the in vitro and in vivo release of potent antimicrobial agents. Flamand L, Tremblay MJ, Borgeat P, J Immunol 2007 178 8036 8045 17548641
11. Leukotriene B§ssub§4§esub§ receptor BLT1 mediates early effector T cell recruitment. Tager AM, Bromley SK, Medoff BD, Islam SA, Bercury SD, Friedrich EB, Carafone AD, Gerszten RE, Luster AD, Nat Immunol 2003 4 982 990 10.1038/ni970 12949531
12. The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis. Lotzer K, Funk KD, Habenich AJR, Biochim Biophys Acta 2005 1736 30 37 16081317
13. Oxidative damage in ischemic stroke revealed using multiple biomarkers. Seet RC, Lee CY, Chan BP, Sharma VK, Teoh HL, Venketasubramanian N, Lim EC, Chong WL, Looi WF, Huang SH, Ong BK, Halliwell B, Stroke 2011 42 2326 2329 10.1161/STROKEAHA.111.618835 21700941
14. Products of 5-lipoxygenase and myeloperoxidase activities are increased in young male cigarette smokers. Loke WM, Lam KMJ, Chong WL, Chew SE, Quek AML, Lim ECH, Seet RCS, Free Radic Res 2012 46 1230 1237 10.3109/10715762.2012.701291 22690830
15. Long-term persistence of clinical symptoms in dengue-infected persons and its association with immunological disorders. García G, González N, Pérez AB, Sierra B, Aguirre E, Rizo D, Izquierdo A, Sánchez L, Díaz D, Lezcay M, Int J Infect Dis 2011 15 38 e43 10.1016/j.ijid.2010.09. 008 21112804
16. Antibody enhancement of respiratory syncytial virus stimulation of leukotriene production by a macrophagelike cell line. Ananaba GA, Anderson LJ, J Virol 1991 65 5052 5060 1870211
17. Human fibroblasts show expression of the leukotriene- A§ssub§4§esub§-hydrolase gene, which is increased after simian-virus-40 transformation. Medina JF, Barrios C, Funk CD, Larsson O, Haeggstrom J, Radmark O, Euro J Biochem 1990 191 27 31 10.1111/j.1432-1033.1990. tb19089.x
18. Epstein-Barr virus modulates 5-lipoxygenase product synthesis in human peripheral blood mononuclear cells. Gosselin J, Borgeat P, Blood 1997 89 2122 2130 9058735
19. Human CMV infection induces 5-lipoxygenase expression and leukotriene B§ssub§4§esub§ production in vascular smooth muscle cells. Qiu H, Straat K, Rahbar A, Wan M, Soderberg-Naucler C, Haeggstrom JZ, J Exp Med 2008 205 19 24 10.1084/jem.20070201 18180307
20. Human immunodeficiency virus glycoprotein (GP120) induction of monocyte arachidonic acid metabolites and interleukin 1. Wahl LM, Corcoran ML, Pyle SW, Arthur LO, Harel-Bellan A, Farrar WL, Proc Natl Acad Sci USA 1989 86 621 625 10.1073/pnas.86.2.621 2536171
21. Release of leukotriene C§ssub§4§esub§ in respiratory tract during acute viral infection. Volovitz B, Faden H, Ogra PL, J Pediatr 1988 112 218 222 10.1016/S0022-3476(88)80058-1 3339502
22. LTB§ssub§4§esub§ increases nasal neutrophil activity and conditions neutrophils to exert antiviral effects. Widegren H, Andersson M, Borgeat P, Flamand L, Johnston S, Greiff L, Respir Med 2011 105 997 1006 10.1016/j.rmed.2010.12.021 21251805
23. Leukotrienes inhibit early stages of HIV-1 infection in monocyte-derived microglia-like cells. Bertin J, Barat C, Bélanger D, Tremblay MJ, J Neuroinflammation 2012 9 55 70 10.1186/1742-2094-9-55 22424294
24. Directional sensing in eukaryotic chemotaxis: A balanced inactivation model. Levine H, Kessler DA, Rappel W-J, Proc Natl Acad Sci 2006 103 9761 9766 10.1073/pnas.0601302103 16782813
25. T-cell trafficking in asthma: lipid mediators grease the way. Luster AD, Tager AM, Nat Rev Immunol 2004 4 711 724 10.1038/nri1438 15343370
26. Expression of 5-lipoxygenase in pulmonary artery endothelial cells. Zhang YY, Walker JL, Huang A, Keaney JF, Clish CB, Serhan CN, Loscalzo J, Biochem J 2002 361 267 276 10.1042/0264-6021:3610267 11772398
27. Release of anti-HIV mediators after administration of leukotriene B§ssub§4§esub§ to humans. Flamand L, Borgeat P, Lalonde R, Gosselin J, J Infect Dis 2004 189 2001 2009 10.1086/386374 15143466
28. Stimulation of interleukin 2 and interferon gamma production by leukotriene B§ssub§4§esub§ in human lymphocyte cultures. Rola-Pleszczynski M, Chavaillaz PA, Lemaire I, Prostaglandins Leukot Med 1986 23 207 210 10.1016/0262-1746(86)90187-3 3020587
29. Leukotrienes augment interleukin 1 production by human monocytes. Rola-Pleszczynski M, Lemaire I, J Immunol 1985 135 3958 3961 2999234
30. The role of leukotrienes in inflammation. Henderson WR Jr, Ann Intern Med 1994 121 684 697 10.7326/0003-4819-121-9-199411010-00010 7944079
31. Inflammation in atherosclerosis. Libby P, Nature 2002 420 868 874 10.1038/nature01323 12490960
32. Leukotriene B§ssub§4§esub§ strongly increases monocyte chemoattractant protein-1 in human monocytes. Huang L, Zhao A, Wong F, Ayala JM, Struthers M, Ujjainwalla F, Wright SD, Springer MS, Evans J, Cui J, Arterioscler Thromb Vasc Biol 2004 24 1783 1788 10.1161/01.ATV.0000140063.06341. 09 15271789
33. Leukotriene B§ssub§4§esub§ receptor antagonism reduces monocytic foam cells in mice. Aiello RJ, Bourassa P-A, Lindsey S, Weng W, Freeman A, Showell HJ, Arterioscler Thromb Vasc Biol 2002 22 443 449 10.1161/hq0302.105593 11884288
34. Neutrophil-derived leukotriene B§ssub§4§esub§ is required for inflammatory arthritis. Chen M, Lam BK, Kanaoka Y, Nigrovic PA, Audoly LP, Austen KF, Lee DM, J Exp Med 2006 203 837 842 10.1084/jem.20052371 16567388
35. Measurement of eicosanoids in cancer tissues. Wang D, DuBois N, Methods Enzymol 2007 433 27 50 17954227
36. Measurement of F§ssub§2§esub§-isoprostanes, hydroxyeicosatetraenoic products, and oxysterols from a single plasma sample. Lee CYJ, Huang SH, Jenner AM, Halliwell B, Free Radical Biol Med 2008 44 1314 1322 10.1016/j.freeradbiomed.2007.12.026
37. Metabolic transformation has a profound effect on anti-inflammatory activity of flavonoids such as quercetin: lack of association between antioxidant and lipoxygenase inhibitory activity. Loke WM, Proudfoot JM, Stewart S, McKinley AJ, Needs PW, Kroon PA, Hodgson JM, Croft KD, Biochem Pharmacol 2008 75 1045 1053 10.1016/j.bcp.2007.11.002 18096136
38. Release of leukotriene B§ssub§4§esub§ from human neutrophils and its relationship to degranulation induced by N-formyl-methionyl-leucyl-phenylalanine, serum-treated zymosan and the ionophore A23187. Palmer R, Salmon J, Immunology 1983 50 65 73 6309653
39. MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes. Rouzer CA, Ford-Hutchinson AW, Morton HE, Gillard JW, J Biol Chem 1990 265 1436 1442 2104841